These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36209784)

  • 1. Stem cell-based multi-tissue platforms to model human autoimmune diabetes.
    Leavens KF; Alvarez-Dominguez JR; Vo LT; Russ HA; Parent AV
    Mol Metab; 2022 Dec; 66():101610. PubMed ID: 36209784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating pancreatic beta-like cells from human pluripotent stem cells.
    Lim LY; Ching C; Kong D; Chan SY; Teo AKK
    Methods Cell Biol; 2022; 170():127-146. PubMed ID: 35811096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and potential applications of human pluripotent stem cell-derived pancreatic β cells.
    Zhou Z; Ma X; Zhu S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):708-715. PubMed ID: 32445468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges.
    Mayhew CN; Wells JM
    Curr Opin Organ Transplant; 2010 Feb; 15(1):54-60. PubMed ID: 19855279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
    Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
    Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
    Manzar GS; Kim EM; Zavazava N
    J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.
    Silva IBB; Kimura CH; Colantoni VP; Sogayar MC
    Stem Cell Res Ther; 2022 Jul; 13(1):309. PubMed ID: 35840987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling different types of diabetes using human pluripotent stem cells.
    Abdelalim EM
    Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta cell-immune cell interface in type 1 diabetes (T1D).
    James EA; Joglekar AV; Linnemann AK; Russ HA; Kent SC
    Mol Metab; 2023 Dec; 78():101809. PubMed ID: 37734713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.
    Sackett SD; Rodriguez A; Odorico JS
    Rev Diabet Stud; 2017; 14(1):39-50. PubMed ID: 28632820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into human beta cell biology using human pluripotent stem cells.
    Amirruddin NS; Low BSJ; Lee KO; Tai ES; Teo AKK
    Semin Cell Dev Biol; 2020 Jul; 103():31-40. PubMed ID: 31757584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the development of insulin-producing cells: Precursors correlated involvement of microRNA panels.
    Pierantoni M; Grassilli S; Brugnoli F; Dell'Aira M; Bertagnolo V
    Life Sci; 2024 Aug; 350():122762. PubMed ID: 38843994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of iPSC-derived beta cells from patients with diabetes.
    Maxwell KG; Millman JR
    Cell Rep Med; 2021 Apr; 2(4):100238. PubMed ID: 33948571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.